Safety and Tolerability of an Intra-seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-interventional Observational Study Investigating the Feasibility During Routine Administration

BACKGROUND AND OBJECTIVE: For specific immunotherapy to pollen allergy, a pre-seasonal start of treatment is recommended by international guidelines. In a placebo-controlled clinical trial with adults, an intra-seasonal start of therapy with the SQ-standardised grass allergy immunotherapy tablet (AI...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwab, Jan-Alexander, Wolf, Hendrik, Schnitker, Jörg, Wüstenberg, Eike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775157/
https://www.ncbi.nlm.nih.gov/pubmed/23943141
http://dx.doi.org/10.1007/s40261-013-0115-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775157/
https://www.ncbi.nlm.nih.gov/pubmed/23943141
http://dx.doi.org/10.1007/s40261-013-0115-8

Ejemplares similares